Nanotechnology-based electrochemical biosensors for monitoring breast cancer biomarkers

Med Res Rev. 2023 May;43(3):464-569. doi: 10.1002/med.21931. Epub 2022 Dec 4.

Abstract

Breast cancer is categorized as the most widespread cancer type among women globally. On-time diagnosis can decrease the mortality rate by making the right decision in the therapy procedure. These features lead to a reduction in medication time and socioeconomic burden. The current review article provides a comprehensive assessment for breast cancer diagnosis using nanomaterials and related technologies. Growing use of the nano/biotechnology domain in terms of electrochemical nanobiosensor designing was discussed in detail. In this regard, recent advances in nanomaterial applied for amplified biosensing methodologies were assessed for breast cancer diagnosis by focusing on the advantages and disadvantages of these approaches. We also monitored designing methods, advantages, and the necessity of suitable (nano) materials from a statistical standpoint. The main objective of this review is to classify the applicable biosensors based on breast cancer biomarkers. With numerous nano-sized platforms published for breast cancer diagnosis, this review tried to collect the most suitable methodologies for detecting biomarkers and certain breast cancer cell types.

Keywords: advanced nanomaterials; breast cancer; diagnosis; electrochemistry; nanotechnology.

Publication types

  • Review

MeSH terms

  • Biomarkers
  • Biomarkers, Tumor
  • Biosensing Techniques* / methods
  • Breast Neoplasms* / diagnosis
  • Electrochemical Techniques / methods
  • Female
  • Humans
  • Nanostructures* / chemistry
  • Nanotechnology / methods

Substances

  • Biomarkers, Tumor
  • Biomarkers